0.91
+0.458(+101.33%)
Currency In USD
| Previous Close | 0.45 |
| Open | 1.03 |
| Day High | 1.45 |
| Day Low | 0.7 |
| 52-Week High | 9.5 |
| 52-Week Low | 0.37 |
| Volume | 121.37M |
| Average Volume | 356,414 |
| Market Cap | 3.39M |
| PE | -0.21 |
| EPS | -4.27 |
| Moving Average 50 Days | 0.52 |
| Moving Average 200 Days | 1.75 |
| Change | 0.46 |
If you invested $1000 in Helius Medical Technologies, Inc. (HSDT) 10 years ago, it would be worth $0.04 as of December 21, 2024 at a share price of $0.91. Whereas If you bought $1000 worth of Helius Medical Technologies, Inc. (HSDT) shares 5 years ago, it would be worth $0.84 as of December 21, 2024 at a share price of $0.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire Inc.
Nov 18, 2024 1:01 PM GMT
Management to host business update call today at 9:00am ETNEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neu
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
GlobeNewswire Inc.
Nov 18, 2024 1:00 PM GMT
NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
GlobeNewswire Inc.
Oct 18, 2024 12:00 PM GMT
NEWTOWN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, toda